Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Mouth Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 12Cisplatin 7Cetuximab 7Carboplatin 7Docetaxel 6Blood Specimen Collection 4Radiotherapy, Intensity-Modulated 3Paclitaxel 3toripalimab 2atezolizumab 2Radiotherapy 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Drug Therapy 2tocilizumab 1regorafenib 1osimertinib 1lenvatinib 1fludarabine 1ficlatuzumab 1cemiplimab 1calcipotriene 1bintrafusp alfa protein, human 1avelumab 1alpha-2'-deoxythioguanosine 1aldesleukin 1aflibercept 1Watchful Waiting 1Vinorelbine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Squamous Cell × Pressure × Clear all
NCT07095608 2025-11-21

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain

New York University

Phase NA Recruiting
80 enrolled
Head & Neck

Carcinoma, Squamous Cell, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡